• Profile
Close

Early control of C-reactive protein levels with non-biologics is associated with slow radiographic progression in radiographic axial spondyloarthritis

International Journal of Rheumatic Diseases Jan 05, 2022

Koo BS, Lee S, Oh JS, et al. - In radiographic axial spondyloarthritis cases, a significant association exists between controlled C-reactive protein (CRP) achieved in response to initial treatment with non-biologic agents for 3 months and a slower rate of spinal radiographic change. In this disease condition, radiographic progression is well-predicted by CRP level at 3 months after initial non-biologic treatment.

  • This study included radiographic axial spondyloarthritis patients observed for 18 years and initially treated with nonsteroidal anti-inflammatory drugs and/or conventional disease-modifying antirheumatic drugs for 3 months.

  • Participants were assigned to two groups: the controlled CRP group (n = 351) comprising patients with a CRP level of <0.8 mg/dL or 50% of the baseline CRP at 3 months; and the uncontrolled CRP group (n = 452) with remaining patients.

  • The controlled CRP group exhibited a slower increase in the modified Stoke Ankylosing Spondylitis Spinal Score compared with the uncontrolled CRP group (interaction term β = −.499, 95% confidence interval −0.699 to −0.300).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay